Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- POAIDELISTED
- Price
- 5.48
- Stock movement up
- +0.05 (0.92%)
- Company name
- Predictive Oncology Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Technology >Software - Infrastructure
- Market cap
- 18.60M
- Ent value
- 98.98M
- Price/Sales
- 25.54
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -55.96%
- 1 year return (CAGR)
- 593.67%
- 3 year return (CAGR)
- -12.28%
- 5 year return (CAGR)
- -18.40%
- 10 year return (CAGR)
- -54.76%
Last updated: 2026-02-12
DIVIDENDS
POAI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 25.54 |
| Price to Book | - |
| EV to Sales | 135.93 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.39M |
| EPS (TTM) | -116.48 |
| FCF per share (TTM) | -12.12 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 728.20K |
| Gross profit (TTM) | 365.87K |
| Operating income (TTM) | -10.35M |
| Net income (TTM) | -84.33M |
| EPS (TTM) | -116.48 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 50.24% |
| Operating margin (TTM) | -1421.38% |
| Profit margin (TTM) | -11581.34% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 181.67K |
| Net receivables | 26.01K |
| Total current assets | 1.10M |
| Goodwill | 0.00 |
| Intangible assets | 47.52K |
| Property, plant and equipment | 3.66M |
| Total assets | 3.14M |
| Accounts payable | 2.72M |
| Short/Current long term debt | 1.70M |
| Total current liabilities | 79.49M |
| Total liabilities | 80.57M |
| Shareholder's equity | -77.43M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -8.78M |
| Capital expenditures (TTM) | 11.00 |
| Free cash flow (TTM) | -8.78M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -2688.13% |
| Return on Invested Capital | 109.81% |
| Cash Return on Invested Capital | 11.43% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.30 |
| Daily high | 5.70 |
| Daily low | 5.29 |
| Daily Volume | 12K |
| All-time high | 262500.00 |
| 1y analyst estimate | 3.00 |
| Beta | 1.35 |
| EPS (TTM) | -116.48 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| POAI | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.49% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 20 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -93.11% | -10.84% |
| Avg time to new high | 522 days | 12 days |
| Max time to new high | 3492 days | 1805 days |
COMPANY DETAILS
Marketcap
18.60M
Marketcap category
Small-cap
Description
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Employees
23
Investor relations
-
SEC filings
CEO
Carl Schwartz
Country
USA
City
Eagan
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner